Home Infusion Therapy Market size worth $26.3 Billion by 2023: Global Market Insights Inc.
May 23, 2016 05:30 ET | Global Market Insights, Inc
Dover, DE, May 23, 2016 (GLOBE NEWSWIRE) -- Home Infusion Therapy Market size is projected to reach USD 26.3 billion by 2023; as per a new research report by Global Market Insights, Inc. Growing...
PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial
May 05, 2016 09:15 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - May 05, 2016) -  PharmaCyte Biotech (OTCQB: PMCB) has now reached a point in its life cycle where it is ready to start working with the U.S. FDA to get the company's...
Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide
April 26, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
Midatech achieves positive dosing data for OpsiSporin Uveitis programme
April 21, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015
April 13, 2016 02:00 ET | Midatech Pharma PLC
Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US
April 11, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...
PharmaCyte Biotech Aims for Consolidated Therapy to Address Unmet Medical Need in Upcoming Cancer Clinical Trial
October 15, 2015 09:25 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - October 15, 2015) - PharmaCyte Biotech’s (OTCQB: PMCB) advanced pancreatic cancer treatment of Cell-in-a-Box® capsules + low-doses of ifosfamide has outperformed Eli...
Inform Genomics logo
Inform Genomics Files Provisional Patent Application with United States Patent and Trademark Office (USPTO) -"Systems and Methods for Predicting Treatment-Regimen-Related Outcomes."
October 05, 2015 08:00 ET | Inform Genomics
Boston, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced...
PharmaCyte Biotech's "Factory" of Live Cells Takes Direct Aim at Cancer Tumors Armed With FDA Orphan Drug Status
March 18, 2015 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - March 18, 2015) - PharmaCyte Biotech (OTCQB: PMCB) is aiming directly at the problem patients with advanced pancreatic cancer face, an inoperable tumor! PharmaCyte owns...
Enterade USA
Enterade USA Appoints Stephen J. Gatto Chief Executive Officer
August 26, 2014 09:00 ET | Enterade
NEWBERRY, Fla. and BOSTON, Aug. 26, 2014 (GLOBE NEWSWIRE) -- Enterade USA, LLC, an innovative health sciences company, announced today the appointment of Stephen J. Gatto as its Chairman and Chief...